$TPET
Trio Petroleum Corp. Stock $tpet

$tpet Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224004144 Filed on January 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.355M	$1.243M	$4.356M
YoY Change	721.1%	1296.8%	462.39%
% of Gross Profit
Research & Development	$84.59K	$26.69K	$251.7K
YoY Change			778.06%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.440M	$1.271M	$4.611M
YoY Change	769.09%	1316.58%	472.02%
Operating Profit	-$1.440M		-$4.611M
YoY Change	769.1%		472.02%
Interest Expense	$159.3K	-$44.88K	$791.8K
YoY Change	-124.41%	-92.71%	-147.64%
% of Operating Profit
Other Income/Expense, Net	-$261.9K	-$3.900K	-$1.934M
YoY Change	-59.87%	-58.73%	45.14%
Pretax Income	-$1.702M	-$1.320M	-$6.544M
YoY Change	108.0%	84.55%	72.2%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$1.702M	-$1.320M	-$6.544M
YoY Change	108.0%	84.55%	72.2%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.05		-$0.28
Diluted Earnings Per Share	-$0.05	-$0.04	-$0.28
COMMON SHARES
Basic Shares Outstanding	31.90M shares		23.08M shares
Diluted Shares Outstanding	31.60M shares		23.08M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$348.8K	$1.562M	$1.562M
YoY Change	209.92%	2020.73%	2020.73%
Cash & Equivalents	$348.7K	$1.562M
Short-Term Investments
Other Short-Term Assets	$127.1K	$133.4K	$133.4K
YoY Change	-93.51%	-92.05%	-92.05%
Inventory
Prepaid Expenses	$127.1K	$133.4K
Receivables
Other Receivables
Total Short-Term Assets	$475.9K	$1.695M	$1.695M
YoY Change	-77.04%	-3.26%	-3.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.86M	$9.948M	$9.948M
YoY Change	86.08%	70.45%	70.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$10.86M	$9.948M	$9.948M
YoY Change	40.38%	28.59%	28.59%
TOTAL ASSETS
Total Short-Term Assets	$475.9K	$1.695M	$1.695M
Total Long-Term Assets	$10.86M	$9.948M	$9.948M
Total Assets	$11.34M	$11.64M	$11.64M
YoY Change	15.57%	22.7%	22.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$561.7K	$609.4K	$609.4K
YoY Change	-60.02%	-47.65%	-47.65%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$1.271M	$1.218M	$1.218M
YoY Change
Total Short-Term Liabilities	$1.927M	$1.851M	$1.851M
YoY Change	-74.09%	-72.41%	-72.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$369.0K	$48.31K	$48.31K
YoY Change	562.73%	-12.15%	-12.15%
Total Long-Term Liabilities	$369.0K	$48.31K	$48.31K
YoY Change	562.73%	-12.13%	-12.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.927M	$1.851M	$1.851M
Total Long-Term Liabilities	$369.0K	$48.31K	$48.31K
Total Liabilities	$2.296M	$1.900M	$1.900M
YoY Change	-69.35%	-71.92%	-71.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.15M	-$10.45M
YoY Change		167.7%
Common Stock	$3.235K	$3.105K
YoY Change		82.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.040M	$9.743M	$9.743M
YoY Change
Total Liabilities & Shareholders Equity	$11.34M	$11.64M	$11.64M
YoY Change	15.57%	22.7%	22.7%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.702M	-$1.320M	-$6.544M
YoY Change	108.0%	84.55%	72.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$774.4K	-$1.494M	-$4.037M
YoY Change	256.11%	197.62%	703.93%
INVESTING ACTIVITIES
Capital Expenditures	$912.5K	$112.5K	$362.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$389.7K	-$273.3K	-$1.828M
YoY Change
Cash From Investing Activities	-$522.8K	-$385.8K	-$2.190M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$738.7K
YoY Change			1120.12%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$84.02K	1.936M	$7.715M
YoY Change	-67.22%	289.64%	1452.56%
NET CHANGE
Cash From Operating Activities	-$774.4K	-1.494M	-$4.037M
Cash From Investing Activities	-$522.8K	-385.8K	-$2.190M
Cash From Financing Activities	$84.02K	1.936M	$7.715M
Net Change In Cash	-$1.213M	55.90K	$1.488M
YoY Change	-3220.31%	-1170.88%	-28611.03%
FREE CASH FLOW
Cash From Operating Activities	-$774.4K	-$1.494M	-$4.037M
Capital Expenditures	$912.5K	$112.5K	$362.0K
Free Cash Flow	-$1.687M	-$1.607M	-$4.399M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001898766
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate		usd
CY2022Q4	TPET	Convertible Note Payable Current ConvertibleNotePayableCurrent		usd
CY2023Q4	TPET	Warrants Liability Current WarrantsLiabilityCurrent		usd
CY2023Q4	TPET	Franchise Tax Accrual FranchiseTaxAccrual		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2023	TPET	Penalty Fees PenaltyFees		usd
CY2022	TPET	Loss On Settlement LossOnSettlement		usd
CY2022	TPET	Loss On Note Conversion LossOnNoteConversion		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	TPET	Stock Issued During Period Value Excercisable Warrants StockIssuedDuringPeriodValueExcercisableWarrants		usd
CY2022	TPET	Stock Issued During Period Value Restricted Stock Award Gross To Outside Directors StockIssuedDuringPeriodValueRestrictedStockAwardGrossToOutsideDirectors		usd
CY2022	TPET	Stock Issued During Period Value Restricted Stock Award Gross To Executives StockIssuedDuringPeriodValueRestrictedStockAwardGrossToExecutives		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	TPET	Conversion Of Spa ConversionOfSPA		usd
CY2022	TPET	Debt Discount DebtDiscount		usd
CY2023	TPET	Writeoff Of Spa Receivable WriteoffOfSPAReceivable		usd
CY2023	TPET	Imputed Interest ImputedInterest		usd
CY2023	TPET	Penalty Fees PenaltyFees		usd
CY2022	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties		usd
CY2022	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2022	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023	us-gaap	Interest Paid InterestPaid		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	TPET	Issuance Of Common Stock For Excercisable Warrants IssuanceOfCommonStockForExcercisableWarrants		usd
CY2022	TPET	Issuance Of Prefunded Warrants IssuanceOfPrefundedWarrants		usd
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Depletion OilAndGasPropertyFullCostMethodDepletion		usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Depletion OilAndGasPropertyFullCostMethodDepletion		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes		pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	TPET	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023	TPET	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-10-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41643
CY2023	dei	Entity Registrant Name EntityRegistrantName	TRIO PETROLEUM CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1968201
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4115 Blackhawk Plaza Circle
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Danville
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94506
CY2023	dei	City Area Code CityAreaCode	(661)
CY2023	dei	Local Phone Number LocalPhoneNumber	324-3911
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	TPET
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	26020517	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31898294	shares
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash Cash	1561924	usd
CY2022Q4	us-gaap	Cash Cash	73648	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	133417	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1643881	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1695341	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1752529	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	9947742	usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	5836232	usd
CY2022Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	1900000	usd
CY2023Q4	us-gaap	Assets Assets	11643083	usd
CY2022Q4	us-gaap	Assets Assets	9488761	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	609360	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1164055	usd
CY2023Q4	us-gaap	Postemployment Benefits Liability Current PostemploymentBenefitsLiabilityCurrent	2778	usd
CY2022Q4	us-gaap	Postemployment Benefits Liability Current PostemploymentBenefitsLiabilityCurrent	2778	usd
CY2023Q4	TPET	Convertible Note Payable Current ConvertibleNotePayableCurrent	1217597	usd
CY2022Q4	TPET	Warrants Liability Current WarrantsLiabilityCurrent	114883	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1851386	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6710652	usd
CY2022Q4	TPET	Franchise Tax Accrual FranchiseTaxAccrual	9450	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	48313	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	45535	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	48313	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	54985	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1899699	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6765637	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31046516	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31046516	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16972800	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16972800	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3105	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1697	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	10010	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	10010	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	20197171	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6633893	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10446882	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3902456	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9743384	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2723124	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11643083	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9488761	usd
CY2023	us-gaap	Exploration Expense ExplorationExpense	251743	usd
CY2022	us-gaap	Exploration Expense ExplorationExpense	28669	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3311886	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	768379	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1044261	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	6202	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	2778	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	2778	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4610668	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	806028	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4610668	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-806028	usd
CY2023	us-gaap	Interest Expense InterestExpense	791811	usd
CY2022	us-gaap	Interest Expense InterestExpense	1661981	usd
CY2022	TPET	Penalty Fees PenaltyFees	1322933	usd
CY2023	TPET	Loss On Settlement LossOnSettlement	13051	usd
CY2023	TPET	Loss On Note Conversion LossOnNoteConversion	1125000	usd
CY2023	us-gaap	Taxes And Licenses TaxesAndLicenses	3896	usd
CY2022	us-gaap	Taxes And Licenses TaxesAndLicenses	9450	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1933758	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2994364	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6544426	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3800392	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6544426	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3800392	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23079750	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14797786	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23079750	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14797786	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2723124	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	372000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	5164875	usd
CY2023	TPET	Stock Issued During Period Value Issuance Of Commitment Shares Related To The Spa StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesRelatedToTheSPA	1125000	usd
CY2023	TPET	Stock Issued During Period Value Issuance Of Common Shares In Ipo Net Of Underwriting Discounts And Offering Costs StockIssuedDuringPeriodValueIssuanceOfCommonSharesInIPONetOfUnderwritingDiscountsAndOfferingCosts	3342626	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	4000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1812635	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	366659	usd
CY2023	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	332630	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1044261	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6544426	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	9743384	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4050510	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4050510	usd
CY2022	TPET	Stock Issued During Period Value Founders Of Shares StockIssuedDuringPeriodValueFoundersOfShares	543	usd
CY2022	TPET	Stock Issued During Period Value Issuance Of Security Interest Shares To Investors StockIssuedDuringPeriodValueIssuanceOfSecurityInterestSharesToInvestors	1322933	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60000	usd
CY2022	TPET	Adjustments To Additional Paid In Capital Issuance Of Warrants In Connection With Investor Financing AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsInConnectionWithInvestorFinancing	994091	usd
CY2022	TPET	Adjustments To Additional Paid In Capital Interest Imputed On Note Payable For Acquisition Of Unproved Oil And Gas Properties AdjustmentsToAdditionalPaidInCapitalInterestImputedOnNotePayableForAcquisitionOfUnprovedOilAndGasProperties	89237	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6202	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3800392	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2723124	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2723124	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6544426	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3800392	usd
CY2023	TPET	Franchise Tax Fee And Income FranchiseTaxFeeAndIncome	-9450	usd
CY2022	TPET	Franchise Tax Fee And Income FranchiseTaxFeeAndIncome	9450	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	25000	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	2778	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	2778	usd
CY2023	TPET	Conversion Of Spa ConversionOfSPA	1125000	usd
CY2023	TPET	Debt Discount DebtDiscount	-140000	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	473240	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1218951	usd
CY2022	TPET	Writeoff Of Spa Receivable WriteoffOfSPAReceivable	80000	usd
CY2022	TPET	Imputed Interest ImputedInterest	89237	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1044261	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	6202	usd
CY2022	TPET	Penalty Fees PenaltyFees	1322933	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	123417	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	13846	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	110180	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	582543	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4036834	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-502144	usd
CY2023	us-gaap	Payments To Explore And Develop Oil And Gas Properties PaymentsToExploreAndDevelopOilAndGasProperties	362022	usd
CY2023	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	3749488	usd
CY2023	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1900000	usd
CY2023	us-gaap	Proceeds From Collection Of Longterm Loans To Related Parties ProceedsFromCollectionOfLongtermLoansToRelatedParties	21651	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2189859	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	738659	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	60543	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	4820000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1472512	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2920000	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	6000000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	350320	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	575438	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1812635	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1013493	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	888190	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7714969	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	496915	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1488276	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5229	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73648	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	78877	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1561924	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	73648	usd
CY2023	TPET	Issuance Of Warrants Equity Classified IssuanceOfWarrantsEquityClassified	332630	usd
CY2022	TPET	Issuance Of Warrants Equity Classified IssuanceOfWarrantsEquityClassified	1108974	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	213	shares
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	30	shares
CY2023	TPET	Issuance Of Common Stock For Excercisable Warrants IssuanceOfCommonStockForExcercisableWarrants	120	usd
CY2023	TPET	Issuance Of Prefunded Warrants IssuanceOfPrefundedWarrants	4000	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80F_eus-gaap--NatureOfOperations_zRWvcY8rHCAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_826_zYASJMkcrUvd">NATURE OF THE ORGANIZATION AND BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Company Organization</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trio Petroleum Corp. (“Trio Petroleum” or the “Company”) is an oil and gas exploration and development company headquartered in Bakersfield, California, with operations in Monterey County, California. The Company was incorporated on July 19, 2021, under the laws of Delaware to acquire, fund and develop oil exploration and production assets in California; it has no revenue-generating operations as of the date of this filing. The Company was formed to acquire Trio Petroleum LLC’s (“Trio LLC”) approximate <span id="xdx_903_eus-gaap--BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_iI_pid_dp_uPure_c20231031__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zc8sRnLCqXla" title="Business acquisition increase in percentage of working interest">82.75</span>% working interest, which was subsequently increased to an approximate <span id="xdx_90F_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20231031__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zFw7EPomKtp2" title="Business acquisition percentage of working interest">85.75</span>% working interest, in the large, approximately 9,300-acre South Salinas Project located in Monterey, California, and subsequently partner with certain members of Trio LLC’s management team to develop and operate those assets. (see Note 5 and Note 6).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition of South Salinas Project</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 14, 2021, the Company entered into a Purchase and Sale Agreement (“Trio LLC PSA”) with Trio LLC to acquire an <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_dp_uPure_c20210914__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember__us-gaap--BusinessAcquisitionAxis__custom--SouthSalinasProjectMember_zEmbfgcV3rg9" title="Business acquisition percentage">82.75</span>% working interest in the South Salinas Project; the working interest included the purchased percentage of the South Salinas Project’s leases, wells and inventory in exchange for $<span id="xdx_90B_eus-gaap--PaymentsToAcquireBusinessesGross_c20210913__20210914__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zFLRzkQ9O903" title="Payments to acquire businesses net of cash acquired">300,000</span> cash, a non-interest-bearing note payable of $<span id="xdx_901_eus-gaap--AccountsPayableInterestBearingCurrentAndNoncurrent_iI_c20211217__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zw6dsMnyi6Ei" title="Non interest bearing notes payable">3,700,000</span> due to Trio LLC on December 17, 2021 (see Note 6 and Note 9) and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20211216__20211217__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zm1l4vHrrwV4" title="Number of shares issued">4,900,000</span> shares of the Company’s $<span id="xdx_90E_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211217__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zCtNzjpoIGy3" title="Common stock price per share">0.0001</span> par value common stock (see Note 5 and Note 10). At the time of the acquisition, this share issuance constituted <span id="xdx_90D_ecustom--BusinessAcquisitionOfOutstandingSharesPercentage_iI_dp_uPure_c20210914__dei--LegalEntityAxis__custom--TrioLLCMember_z2JKf0v6k7X4" title="Business acquisition percentage.">45</span>% of the total number of issued shares of the Company. The Company accounted for the purchase as an asset acquisition, as prescribed in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 805 – <i>Business Combinations</i>. The assets and associated asset retirement obligations (“ARO”) were recorded based on relative fair value at the estimated fair value of the consideration paid (see Note 5). In April 2023, the Company purchased an additional <span id="xdx_90D_ecustom--PurchaseOfAdditionalInterestPercentage_iI_dp_uPure_c20230430__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zycJoLh0oSX3" title="Working interest percentage">3</span>% working interest in the South Salinas Project; see Note 5 for further information. As of October 31, 2023 and 2022, there were no proved reserves attributable to the approximate <span id="xdx_900_eus-gaap--AreaOfLand_iI_usqft_c20231031__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zz9ppefwIzpi" title="Acres of property"><span id="xdx_909_eus-gaap--AreaOfLand_iI_usqft_c20221031__us-gaap--TypeOfArrangementAxis__custom--PurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--TrioLLCMember_zOGxnzcFh5n6" title="Acres of property">9,300</span></span> acres of the property.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Initial Public Offering</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s Registration Statement (Amendment No. 9) on Form S-1/A was filed with the SEC on March 24, 2023; its Initial Public Offering was declared effective on April 17, 2023 and closed on April 20, 2023 (collectively, the “Offering” or “IPO”). The Company sold <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230420__20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziH1DWHqUpAj" title="Number of shares sold">2,000,000</span> shares of its common stock for total gross proceeds of $<span id="xdx_90E_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230420__20230420__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zOjCdQdjeECa" title="Gross proceeds from sale of shares">6,000,000</span>, which is described more fully in Note 4.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Emerging Growth Company</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zVhWripfbpeb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zHpyOYpWzRPl">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transaction and disclosure of contingent assets and liabilities at the date of the financial statements, and the revenue and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates required to be made by management include estimates of oil and natural gas reserves (when and if assigned) and related present value estimates of future net cash flows therefrom, the carrying value of oil and natural gas properties, accounts receivable, bad debt expense, ARO and the valuation of equity-based transactions. Accordingly, actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	133417	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	35000	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1643881	usd
CY2023Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	350320	usd
CY2022Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	575438	usd
CY2023Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	0	usd
CY2022Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	0	usd
CY2021Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	45535	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	2778	usd
CY2022Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	48313	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	2778	usd
CY2023Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	51091	usd
CY2023Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	2778	usd
CY2023Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	48313	usd
CY2023Q4	us-gaap	Cash Cash	1561924	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	396247	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4486964	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1766702	shares
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84D_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zLfreJaD2K2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zu1hfQPSZQ2">Reclassification of Expenses</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain amounts in the prior periods presented have been reclassified to the current period financial statement presentation. This reclassification has no effect on previously reported net income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2023Q4	TPET	Working Capital WorkingCapital	156045	usd
CY2023Q4	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4940000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10446882	usd
CY2023Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	4940000	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	9947742	usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Gross OilAndGasPropertyFullCostMethodGross	5836232	usd
CY2023Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	9947742	usd
CY2022Q4	us-gaap	Oil And Gas Property Full Cost Method Net OilAndGasPropertyFullCostMethodNet	5836232	usd
CY2023	us-gaap	Exploration Costs ExplorationCosts	251743	usd
CY2022	us-gaap	Exploration Costs ExplorationCosts	28669	usd
CY2023	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	4111510	usd
CY2023	us-gaap	Acquisition Costs AcquisitionCosts	262022	usd
CY2022Q4	TPET	Non Refundable Payment NonRefundablePayment	252512	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	8417	acre
CY2022Q2	TPET	Non Refundable Payment NonRefundablePayment	252512	usd
CY2023	us-gaap	Cost Depletion CostDepletion	0	usd
CY2022Q4	TPET	Option Fee OptionFee	150000	usd
CY2023Q4	TPET	Reserve Analysis Optioned Asset ReserveAnalysisOptionedAsset	39000	usd
CY2023Q4	TPET	Payment Of Execution PaymentOfExecution	100000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	400000	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	usd
CY2023	TPET	Working Interest Percentage WorkingInterestPercentage	0.8575	pure
CY2023Q4	TPET	Payment Of Execution PaymentOfExecution	100000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	400000	usd
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.27
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1095000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	797000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1095000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	797000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1095000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	797000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	1095000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	797000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	298000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	776000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21	pure
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1217597	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	1217597	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	5428936	usd
CY2023Q4	TPET	Number Of Shares Required To Reserve And Register NumberOfSharesRequiredToReserveAndRegister	13161976	shares
CY2023Q4	TPET	Percentage Of Common Shares Required To Reserve PercentageOfCommonSharesRequiredToReserve	2	pure
CY2023Q4	TPET	Percentage Of Shares Required To Reserve Upon Conversion Of Note PercentageOfSharesRequiredToReserveUponConversionOfNote	2	pure
CY2023Q4	TPET	Aggregate Authorized Shares AggregateAuthorizedShares	500000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	490000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	TPET	Resale Amendment Agreement Description ResaleAmendmentAgreementDescription	the Company issued a Form S-1/A, which registered for resale (i) up to 3,149,314 shares of common stock, par value $0.0001 per share which the selling stockholders may acquire upon the exercise of outstanding common warrants and (ii) up to 500,000 shares of common stock, which the selling stockholders may acquire upon the exercise of outstanding pre-funded warrants. Such warrants were issued to the selling stockholders in connection with securities purchase agreements entered into on January 28, 2022 and September 20, 2022. The Company recorded 699,848 shares of common stock that are not exercised but registered in accordance with their common warrant agreements and 500,000 shares of common stock that are not exercised but registered in accordance with their pre-funded warrant agreements upon the filing of this Form S-1/A
CY2023Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1000000	shares
CY2023Q4	us-gaap	Share Price SharePrice	0.27
CY2023Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	271000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The restricted stock grant vests over a period of two years, with 25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3341	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	267659	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P3Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	4776046	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.04
CY2023	TPET	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P3Y1M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	2901298	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.03
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	108047	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1766702	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.12
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	211200	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1766702	shares
CY2023Q4	TPET	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercisable Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisableExercisePrice	1.12
CY2023	TPET	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Exercisable Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingExercisableContractualTerm1	P3Y10M24D
CY2023Q4	TPET	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValueExercisable	211200	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0436	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.371	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure

Files In Submission

Name	View Source	Status
0001493152-24-004144-index-headers.html	Edgar Link	pending
0001493152-24-004144-index.html	Edgar Link	pending
0001493152-24-004144.txt	Edgar Link	pending
0001493152-24-004144-xbrl.zip	Edgar Link	pending
ex19-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-2.htm	Edgar Link	pending
ex97.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpet-20231031.xsd	Edgar Link	pending
tpet-20231031_def.xml	Edgar Link	unprocessable
tpet-20231031_cal.xml	Edgar Link	unprocessable
tpet-20231031_lab.xml	Edgar Link	unprocessable
tpet-20231031_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TPET
Trio Petroleum Corp. Stock $tpet

2024 Q1 Form 10-K Financial Statement

#000149315224004144 Filed on January 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPET Trio Petroleum Corp. Stock $tpet

2024 Q1 Form 10-K Financial Statement

#000149315224004144 Filed on January 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPET
Trio Petroleum Corp. Stock $tpet